There is an urgent need for cultural humility in psychedelic science in order to prevent it from falling into the same limiting, and often unethical, traps that we see in Western science and medicine.

MDMA-assisted psychotherapy gave me the ability to feel compassion and empathy for myself.

Renaming adverse effects of psychedelic drugs as “challenging experiences” minimizes, almost trivializes, their negative effects.

As a teenager, I was taking ten milligrams of Ritalin daily. Later, I grew to love the way these pills made it easier for me not to eat.

I came to a working hypothesis: at the center of the mystical experience is awe, wherein one is in the presence of something so great, so large, that it requires they completely reorder their mental structures - completely change the way they view reality.

Why researchers like Alan Kooi Davis — the newest addition to the Johns Hopkins psychedelic research team — decide to devote their careers to studying psychedelics.

We need new drugs. The opioid epidemic gripping the United States has brought into public awareness a problem that has bedeviled the world of medical science for decades: is it possible to have a truly powerful painkiller that is not addictive?

Today, we have a world where we can say: “I’m proud to be a woman” and “I’m proud to be gay.” But we can’t say: “I’m a drug-user.”

A team of researchers bathed octopuses in MDMA. Here's what they learned.

Narratives which gloss-over the history and socioeconomic dynamics of ayahuasca’s globalization may, despite good intentions, actually do more harm than good.